Efthimios, Dardiotis
Georgios, Karachalios
Antonia, Alexopoulou
Rania, Gourgioti http://orcid.org/0000-0002-7421-9035
Maria-Eleutheria, Evangelopoulos
,
Funding for this research was provided by:
Genesis Pharma
Article History
Accepted: 1 August 2021
First Online: 24 August 2021
Declarations
:
: This study was funded by Genesis Pharma S.A.
: The authors declare the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Prof. Dardiotis received grants, consulting fees and travel support from Bayer, Novartis, Genesis Pharma, Genzyme-Sanofi, Merck-Serono, Roche and Teva. Dr. Evangelopoulou received grants and consulting fees from Roche, Merck, Biogen, Teva and Genzyme. George Karachalios, Alexopoulou Tania, Rania Gourgioti are employees of Genesis Pharma SA. No other potential conflict of interest relevant to this article was reported.
: The authors declare that all relevant data supporting the findings of this study are available within the article.
: Not applicable
: All authors contributed to the study conception and design, as well as the collection, analysis, and interpretation of data. All authors read and approved the final manuscript.
: The study was approved by the ethics committees of all participating sites.
: Informed consent was obtained from all individual participants included in the study.
: Not applicable.